MedPath

AKITA UNIVERSITY HOSPITAL

🇯🇵Japan
Ownership
-
Established
1971-01-01
Employees
-
Market Cap
-
Website
http://www.hos.akita-u.ac.jp/

Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer

Phase 1
Suspended
Conditions
Bile Duct Cancer
Interventions
Biological: Peptide vaccine for URLC10
Drug: Gemcitabine
First Posted Date
2008-02-26
Last Posted Date
2015-06-23
Lead Sponsor
Akita University Hospital
Target Recruit Count
9
Registration Number
NCT00624182
Locations
🇯🇵

Akita University Hosipital, Akita, Japan

© Copyright 2025. All Rights Reserved by MedPath